Arlington Capital has acquired TEAM Technologies, a US-based medical device manufacturer, in order to expand its healthcare portfolio.
The undisclosed deal sees Arlington taking over TEAM Technologies from Clearlake Capital. This acquisition aligns with Arlington's focus on strengthening its position in the healthcare sector, particularly in the realm of advanced medical devices.
TEAM Technologies is known for its expertise in manufacturing and providing strategic supply chain solutions for medical device and pharmaceutical original equipment manufacturers (OEMs). The company aims to support leading healthcare OEMs in meeting their design and manufacturing needs while enhancing supply chain efficiency.
Matt Altman, managing partner at Arlington Capital, emphasized the importance of TEAM Technologies in providing critical goods to end users and reinforcing healthcare supply chains. Gordon Auduong, a principal at Arlington, expressed enthusiasm about collaborating with TEAM Technologies' management team and indicated plans for further growth through both organic investments and strategic acquisitions.
Marshall White, CEO of TEAM Technologies, views Arlington as the ideal partner to accelerate the company's growth trajectory. Arlington Capital is deploying capital from its $3.8 billion VI Fund, which has a diverse investment portfolio that includes over 175 companies across various sectors, including healthcare. The firm has a history of making significant investments in the healthcare industry.
The acquisition of TEAM Technologies is part of a broader trend in private equity, where firms are increasingly targeting healthcare companies to capitalize on the growing demand for innovative medical solutions. Arlington Capital enlisted the expertise of Harris Williams as its financial advisor and Goodwin Procter LLP as its legal advisor in navigating the acquisition process. This strategic advisory support underscores the complexity of private equity transactions in the healthcare sector.
The healthcare private equity landscape has seen notable activity recently, with other significant deals reflecting a robust interest in healthcare investments. As Arlington Capital integrates TEAM Technologies into its portfolio, the firm is poised to leverage its resources and expertise to enhance the company's capabilities. This acquisition not only strengthens Arlington's healthcare offerings but also positions TEAM Technologies for accelerated growth in a competitive market.